Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 94

1.

The Role of European Healthcare Databases for Post-Marketing Drug Effectiveness, Safety and Value Evaluation: Where Does Italy Stand?

Trifirò G, Gini R, Barone-Adesi F, Beghi E, Cantarutti A, Capuano A, Carnovale C, Clavenna A, Dellagiovanna M, Ferrajolo C, Franchi M, Ingrasciotta Y, Kirchmayer U, Lapi F, Leone R, Leoni O, Lucenteforte E, Moretti U, Mugelli A, Naldi L, Poluzzi E, Rafaniello C, Rea F, Sultana J, Tettamanti M, Traversa G, Vannacci A, Mantovani L, Corrao G.

Drug Saf. 2018 Sep 29. doi: 10.1007/s40264-018-0732-5. [Epub ahead of print] Review.

PMID:
30269245
2.

[Adaptive studies to assess drug effectiveness].

Bruzzi P, Traversa G.

Epidemiol Prev. 2018 May-Aug;42(3-4):251-253. doi: 10.19191/EP18.3-4.P251.073. Italian.

PMID:
30066527
3.

Comparative Safety of Originator and Biosimilar Epoetin Alfa Drugs: An Observational Prospective Multicenter Study.

Stoppa G, D'Amore C, Conforti A, Traversa G, Venegoni M, Taglialatela M, Leone R; ESAVIEW Study Group.

BioDrugs. 2018 Aug;32(4):367-375. doi: 10.1007/s40259-018-0293-2.

4.

Cardiovascular diseases monitoring: lessons from population-based registries to address future opportunities and challenges in Europe.

Palmieri L, Veronesi G, Corrao G, Traversa G, Ferrario MM, Nicoletti G, Di Lonardo A, Donfrancesco C, Carle F, Giampaoli S.

Arch Public Health. 2018 Jun 28;76:31. doi: 10.1186/s13690-018-0283-3. eCollection 2018.

5.

[Conflict of interest and public health body: the bias and the rule].

Traversa G, Venegoni M.

Epidemiol Prev. 2018 Mar-Apr;42(2):105. doi: 10.19191/EP18.2.P105.032. Italian. No abstract available.

PMID:
29774700
6.

Pattern of Use of Biosimilar and Originator Somatropin in Italy: A Population-Based Multiple Databases Study During the Years 2009-2014.

Marcianò I, Ingrasciotta Y, Giorgianni F, Ientile V, Chinellato A, Tari DU, Gini R, Cannavò S, Pastorello M, Scondotto S, Cananzi P, Traversa G, Trotta F, Belleudi V, Addis A, Trifirò G.

Front Endocrinol (Lausanne). 2018 Mar 13;9:95. doi: 10.3389/fendo.2018.00095. eCollection 2018.

7.

[Which efficacy trials for drugs for rare diseases?]

Traversa G, Trotta F.

Epidemiol Prev. 2017 Sep-Dec;41(5-6):318-319. doi: 10.19191/EP17.5-6.P318.099. Italian. No abstract available.

PMID:
29119773
8.

[Health, public health, research, and participation. Considerations on the Italian ''Vaccination decree''].

Micheli A, Barbone F, Biggeri A, Capocaccia R, Davoli M, Pirastu R, Richiardi L, Traversa G, Forastiere F.

Epidemiol Prev. 2017 May-Aug;41(3-4):149-151. doi: 10.19191/EP17.3-4.P149.039. Italian. No abstract available.

PMID:
28929702
9.

New device to implement the adenoma detection rate.

Zippi M, Hong W, Crispino P, Traversa G.

World J Clin Cases. 2017 Jul 16;5(7):258-263. doi: 10.12998/wjcc.v5.i7.258. Review.

10.

Italian consumption of plasma-derived factor VIII after the SIPPET study.

Traversa G, Trotta F.

Blood Transfus. 2017 May;15(3):283-284. doi: 10.2450/2017.0035-17. No abstract available.

11.

Cardiovascular safety of tiotropium Respimat vs HandiHaler in the routine clinical practice: A population-based cohort study.

Trotta F, Spila-Alegiani S, Da Cas R, Rajevic M, Conti V, Venegoni M, Rossi M, Traversa G.

PLoS One. 2017 Apr 21;12(4):e0176276. doi: 10.1371/journal.pone.0176276. eCollection 2017.

12.

Retrospective comparison of long-term ten-day/month rifaximin or mesalazine in prevention of relapse in acute diverticulitis.

Festa V, Spila Alegiani S, Chiesara F, Moretti A, Bianchi M, Dezi A, Traversa G, Koch M.

Eur Rev Med Pharmacol Sci. 2017 Mar;21(6):1397-1404.

13.

Can systematic reviews contribute to regulatory decisions?

Barbui C, Addis A, Amato L, Traversa G, Garattini S.

Eur J Clin Pharmacol. 2017 Apr;73(4):507-509. doi: 10.1007/s00228-016-2194-y. Epub 2017 Jan 7. Review.

PMID:
28064354
14.

Intramural hematoma of the esophagus: An unusual complication of endoscopic retrograde cholangiopancreatography.

Zippi M, Hong W, Traversa G.

Turk J Gastroenterol. 2016 Nov;27(6):560-561. doi: 10.5152/tjg.2016.16417. No abstract available.

15.

[Biomedical research from philanthropy to scarcity.]

Addis A, De Fiore L, Traversa G.

Recenti Prog Med. 2016 Oct;107(10):507-509. doi: 10.1701/2454.25698. Italian.

PMID:
27782225
16.

How did the Introduction of Biosimilar Filgrastim Influence the Prescribing Pattern of Granulocyte Colony-Stimulating Factors? Results from a Multicentre, Population-Based Study, from Five Italian Centres in the Years 2009-2014.

Marcianò I, Ingrasciotta Y, Giorgianni F, Bolcato J, Chinellato A, Pirolo R, Di Giorgio A, Manna S, Ientile V, Gini R, Santarpia M, Genazzani AA, Uomo I, Pastorello M, Pollina Addario SW, Scondotto S, Cananzi P, Da Cas R, Traversa G, Rossi M, Sottosanti L, Caputi AP, Trifirò G.

BioDrugs. 2016 Aug;30(4):295-306. doi: 10.1007/s40259-016-0175-4.

PMID:
27138636
17.

Italian program for independent research on drugs: 10 year follow-up of funded studies in the area of rare diseases.

Traversa G, Masiero L, Sagliocca L, Trotta F.

Orphanet J Rare Dis. 2016 Apr 12;11:36. doi: 10.1186/s13023-016-0420-4.

18.

Incidental diagnosis of large colic submucosal lipomas during colorectal cancer screening: What we have to do?

Zippi M, Marzano C, Cassieri C, Crispino P, Traversa G.

Clin Ter. 2016;167(1):16-7. doi: 10.7417/CT.2016.1910. No abstract available.

PMID:
26980634
19.

Endoscopic band ligation for gastric antral vascular ectasia: time for a new indication?

Marzano C, Zippi M, Traversa G.

Endoscopy. 2016 Feb;48(2):196. doi: 10.1055/s-0034-1393345. Epub 2016 Jan 28. No abstract available.

PMID:
26820079
20.

Switching Between Epoetins: A Practice in Support of Biosimilar Use.

D'Amore C, Da Cas R, Rossi M, Traversa G.

BioDrugs. 2016 Feb;30(1):27-32. doi: 10.1007/s40259-015-0155-0.

21.

Antihypertensive drug use during pregnancy: a population based study.

D'Amore C, Trotta F, Da Cas R, Zocchetti C, Cocci A, Traversa G.

Ann Ist Super Sanita. 2015;51(3):236-43. doi: 10.4415/ANN_15_03_12.

22.

[Considerations on what we can (and what we should not) ask to registries].

Addis A, Berti E, De Palma R, Fiori G, Papini D, Traversa G; Aziende Farmaceutiche partecipanti al gruppo di lavoro PRIER II.

Recenti Prog Med. 2015 Sep;106(9):444-54. doi: 10.1701/1996.21594. Italian.

PMID:
26418506
23.

[Considerations on limits and profits of registries].

Addis A, Costa E, De Palma R, Magrini N, Marata AM, Martelli L, Papini D, Traversa G; Aziende Farmaceutiche partecipanti ai lavori del PRIER II.

Recenti Prog Med. 2015 Sep;106(9):425-35. doi: 10.1701/1996.21590. Italian.

PMID:
26418504
24.

[Vaccines are drugs].

Traversa G, Raschetti R.

Epidemiol Prev. 2015;39(3):145-6. Italian. No abstract available.

PMID:
26407462
25.

Risk factors influencing the prescription of tiotropium Respimat formulation: a population-based cohort study.

Trotta F, Da Cas R, Rajevic M, Rossi M, Traversa G.

BMJ Open. 2015 May 25;5(5):e006619. doi: 10.1136/bmjopen-2014-006619.

26.

A rare case of gastrointestinal bleeding due to celiax axis stenosis with subsequent hypertrophied pancreaticoduodenal arcades.

Zippi M, Bruni A, Traversa G, Marzano C, Cassieri C, Occhigrossi G, Scevola G.

Clin Ter. 2015;166(1):43-4. doi: 10.7417/CT.2015.1801. No abstract available.

PMID:
25756260
27.

Generic substitution of antidiabetic drugs in the elderly does not affect adherence.

Trotta F, Da Cas R, Maggini M, Rossi M, Traversa G.

Ann Ist Super Sanita. 2014;50(4):333-40. doi: DOI: 10.4415/ANN_14_04_07.

28.

Triptan use in Italy: Insights from administrative databases.

Da Cas R, Nigro A, Terrazzino S, Sances G, Viana M, Tassorelli C, Nappi G, Cargnin S, Pisterna A, Traversa G, Genazzani AA.

Cephalalgia. 2015 Jun;35(7):619-26. doi: 10.1177/0333102414550419. Epub 2014 Sep 22. Erratum in: Cephalalgia. 2015 Sep;35(10):938.

PMID:
25246521
29.

Role of endoscopic sphincterotomy of the minor papilla in pancreas divisum.

Zippi M, Familiari P, Traversa G, De Felici I, Febbraro I, Occhigrossi G, Severi C.

Clin Ter. 2014;165(4):e312-6. doi: 10.7417/CT.2014.1748. Review.

PMID:
25203348
30.

Efficacy and safety of endoscopic retrograde cholangiopancreatography (ERCP) performed in patients with Periampullary duodenal diverticula (PAD).

Zippi M, Traversa G, Pica R, De Felici I, Cassieri C, Marzano C, Occhigrossi G, Paoluzi P.

Clin Ter. 2014;165(4):e291-4. doi: 10.7417/CT.2014.1745.

PMID:
25203345
31.

[The Avastin-Lucentis case: between protection of the competition and public health].

Traversa G.

Epidemiol Prev. 2014 Mar-Apr;38(2):84-6. Italian. No abstract available.

PMID:
24986403
32.

Vaccine effectiveness against severe laboratory-confirmed influenza in children: results of two consecutive seasons in Italy.

Menniti-Ippolito F, Da Cas R, Traversa G, Santuccio C, Felicetti P, Tartaglia L, Trotta F, Di Pietro P, Barabino P, Renna S, Riceputi L, Tovo PA, Gabiano C, Urbino A, Baroero L, Le Serre D, Virano S, Perilongo G, Daverio M, Gnoato E, Maretti M, Galeazzo B, Rubin G, Scanferla S, Da Dalt L, Stefani C, Zerbinati C, Chiappini E, Sollai S, De Martino M, Mannelli F, Becciani S, Giacalone M, Montano S, Remaschi G, Stival A, Furbetta M, Abate P, Leonardi I, Pirozzi N, Raucci U, Reale A, Rossi R, Russo C, Mancinelli L, Manuela O, Carlo C, Mores N, Romagnoli C, Chiaretti A, Compagnone A, Riccardi R, Delogu G, Sali M, Prete V, Tipo V, Dinardo M, Auricchio F, Polimeno T, Sodano G, Maccariello A, Rafaniello C, Fucà F, Di Rosa E, Altavilla D, Mecchio A, Arrigo T; Italian Multicentre Study Group for Drug and Vaccine Safety in Children.

Vaccine. 2014 Jul 31;32(35):4466-70. doi: 10.1016/j.vaccine.2014.06.048. Epub 2014 Jun 21.

33.

Evaluation of safety of A/H1N1 pandemic vaccination during pregnancy: cohort study.

Trotta F, Da Cas R, Spila Alegiani S, Gramegna M, Venegoni M, Zocchetti C, Traversa G.

BMJ. 2014 May 29;348:g3361. doi: 10.1136/bmj.g3361.

34.

Benign pneumoperitoneum after percutaneous endoscopic gastrostomy (PEG) feeding tube placement: do not be afraid!

Zippi M, Pica R, Marzano C, Cassieri C, Avallone EV, Traversa G.

Clin Ter. 2014;165(1):e76-8. doi: 10.7417/CT.2014.1677.

PMID:
24589967
35.

Gastric Dieulafoy's lesion successfully treated by "adjuvant" arterial embolization and endoscopic clipping.

Zippi M, Traversa G, Bruni A, Pica R, Occhigrossi G, Scevola G.

Clin Ter. 2013;164(6):e511-3. doi: 10.7417/CT.2013.1647.

PMID:
24424233
36.

Endoscopic papillary balloon dilation for difficult common bile duct stones: Our experience.

Zippi M, De Felici I, Pica R, Traversa G, Occhigrossi G.

World J Clin Cases. 2013 Apr 16;1(1):19-24. doi: 10.12998/wjcc.v1.i1.19.

37.

Comparison of endoscopic retrograde cholangiopancreatography between elderly and younger patients for common bile duct stones.

Zippi M, De Felici I, Pica R, Occhigrossi G, Traversa G.

Clin Ter. 2013;164(5):e353-8. doi: 10.7417/CT.2013.1612.

PMID:
24217834
38.

Stevens-johnson syndrome associated with drugs and vaccines in children: a case-control study.

Raucci U, Rossi R, Da Cas R, Rafaniello C, Mores N, Bersani G, Reale A, Pirozzi N, Menniti-Ippolito F, Traversa G; Italian Multicenter Study Group For Vaccine Safety In Drug And Children.

PLoS One. 2013 Jul 16;8(7):e68231. doi: 10.1371/journal.pone.0068231. Print 2013.

39.

[The Stamina case: reflections upon an emergency].

Traversa G.

Epidemiol Prev. 2013 Mar-Jun;37(2-3):107-8. Italian. No abstract available.

PMID:
23851237
40.

[A perspective for the role of drug registries in the post-marketing surveillance].

Traversa G, Sagliocca L, Magrini N, Venegoni M.

Recenti Prog Med. 2013 Jun;104(6):280-7. doi: 10.1701/1295.14331. Italian.

PMID:
23801234
41.

[The role of drug registries in the post-marketing surveillance].

Traversa G, Sagliocca L, Magrini N, Venegoni M.

Recenti Prog Med. 2013 Jun;104(6):225-8. doi: 10.1701/1295.14321. Italian.

PMID:
23801224
42.

Self-expandable metal stent placement for treatment of severe sphincterotomy bleeding.

Zippi M, De Felici I, Pica R, Agus MA, Solinas A, Occhigrossi G, Traversa G.

Clin Ter. 2013;164(1):e27-9. doi: 10.7417/CT.2013.1517.

43.

A pragmatic strategy for the review of clinical evidence.

Sagliocca L, De Masi S, Ferrigno L, Mele A, Traversa G.

J Eval Clin Pract. 2013 Aug;19(4):689-96. doi: 10.1111/jep.12020. Epub 2013 Jan 15.

PMID:
23317014
44.

[Use of argon plasma coagulation in digestive endoscopy: a concise review].

Zippi M, Traversa G, Cocco A, Pica R, Cassieri C, Avallone EV, Occhigrossi G.

Clin Ter. 2012 Nov;163(6):e435-40. Review. Italian.

PMID:
23306759
45.

Drug use and upper gastrointestinal complications in children: a case-control study.

Bianciotto M, Chiappini E, Raffaldi I, Gabiano C, Tovo PA, Sollai S, de Martino M, Mannelli F, Tipo V, Da Cas R, Traversa G, Menniti-Ippolito F; Italian Multicenter Study Group for Drug and Vaccine Safety in Children.

Arch Dis Child. 2013 Mar;98(3):218-21. doi: 10.1136/archdischild-2012-302100. Epub 2012 Dec 21.

46.

Hematemesis from esophageal varices associated with esophageal perforation: sclerotherapy and endoscopic clipping.

Zippi M, Traversa G, Pica R, Occhigrossi G.

Eur Rev Med Pharmacol Sci. 2012 May;16(5):704-6.

PMID:
22774417
47.

[Endoscopic therapy with balloon dilatation in patients with colonic post anastomotic strictures. Personal experience].

Zippi M, Traversa G, De Felici I, Febbraro I, Mattei E, Pica R, Occhigrossi G.

Clin Ter. 2011;162(6):539-42. Italian.

PMID:
22262324
48.

Behavior of aqueous nanocrystalline hydroxyapatite in oral bone regeneration.

Zaffe D, Traversa G, Mozzati M, Morelli F, D'Angeli G.

J Appl Biomater Biomech. 2011 Jan-Apr;9(1):19-25. doi: 10.5301/JABB.2011.6450.

PMID:
21425120
49.

Sudden unexpected deaths and vaccinations during the first two years of life in Italy: a case series study.

Traversa G, Spila-Alegiani S, Bianchi C, Ciofi degli Atti M, Frova L, Massari M, Raschetti R, Salmaso S, Scalia Tomba G; Hera Study Group.

PLoS One. 2011 Jan 26;6(1):e16363. doi: 10.1371/journal.pone.0016363.

50.

The need to promote independent research on drugs.

Traversa G, Sagliocca L, Liberati A, Martini N.

Ann Oncol. 2010 Nov;21(11):2295. doi: 10.1093/annonc/mdq571. Epub 2010 Sep 20. No abstract available.

PMID:
20855466

Supplemental Content

Loading ...
Support Center